The first heart unchanged
Release time:
2020-08-14
#, the Party Committee of Jianfeng Pharmaceutical Company organized a party day activity with the theme of "learning party history, knowing party kindness, following the party and being a qualified party member". It visited Jinhua Red Education Base in Jinhua Archives Bureau to review the party history of the Communist Party of China and the party's struggle history in Jinhua, looking back on the hardships of the Chinese Communists in the past hundred years, I feel that the martyrs have made great contributions and sacrifices for the victory of the revolution and the immortal faith that has always been burning in their hearts.
In 1921 , a secret meeting held in Shikumen, Shanghai, opened up a "thousand-year-old change". At that time, a small party with only a few dozen members has now become the world's largest ruling party with more than 118900 members. After the founding of New China in 1949 , the Communist Party of China led the people and embarked on a unique road of Chinese construction.
, Comrade Deng Xiaoping first proposed the "reform and opening up", which created a huge ship sailing towards modernization, China, creating an earth-shattering miracle of development. Jiang Zhuyun, Lei Feng, Jiao Yulu, Wang Jinxi, Kong Fansen in the history of Chinese revolutionary struggle, Shao Piaoping, Qian Jiaju, Zhuo Lanfang and others in the history of Jinhua revolutionary struggle, for the victory of the revolution, they can abandon all generosity to die, for the sake of the tens of thousands of Chinese people, they are willing to dedicate themselves. They are the Communist Party of China, a banner, and an example for our generation to learn from. Comrade Xi Jinping, General Secretary of the Party, said in the report of the 19th National Congress of the Communist Party of China that the original intention and mission of the Chinese Communists is to seek happiness for the Chinese people and rejuvenation for the Chinese nation. I submitted an application for joining the party in 2004 , became a probationary party member in 2006 , and became a full party member with honor in 2007
As a party member engaged in medical work, our original intention and mission is to make medicine of conscience, to produce and sell medicine that people can use at ease. "No matter how far you go, no matter how glorious the future is, you can't forget the past and why you started." Why should I join the Communist Party of China? I think time and action can prove it. In the past, present or future, I am willing to fulfill my obligations as a party member, implement the party's decisions, strictly abide by the party's discipline, keep the party's secrets, be loyal to the party, never betray the party, work actively, and fight for communism for life. The first heart unchanged, continue to move forward. (Lang Minxiao)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31